Sama, Shashank

Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-junction Adenocarcinoma After Pembrolizumab. [electronic resource] - Cureus Jun 2019 - e4862 p. digital

Publication Type: Case Reports; Journal Article

2168-8184

10.7759/cureus.4862 doi